1. Home
  2. COEP vs ORIS Comparison

COEP vs ORIS Comparison

Compare COEP & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ORIS
  • Stock Information
  • Founded
  • COEP 2017
  • ORIS 2014
  • Country
  • COEP United States
  • ORIS China
  • Employees
  • COEP N/A
  • ORIS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ORIS Farming/Seeds/Milling
  • Sector
  • COEP Health Care
  • ORIS Consumer Staples
  • Exchange
  • COEP Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • COEP 32.4M
  • ORIS 30.4M
  • IPO Year
  • COEP N/A
  • ORIS 2024
  • Fundamental
  • Price
  • COEP $11.54
  • ORIS $1.14
  • Analyst Decision
  • COEP
  • ORIS
  • Analyst Count
  • COEP 0
  • ORIS 0
  • Target Price
  • COEP N/A
  • ORIS N/A
  • AVG Volume (30 Days)
  • COEP 136.7K
  • ORIS 321.3K
  • Earning Date
  • COEP 03-25-2025
  • ORIS 02-21-2025
  • Dividend Yield
  • COEP N/A
  • ORIS N/A
  • EPS Growth
  • COEP N/A
  • ORIS N/A
  • EPS
  • COEP N/A
  • ORIS 0.43
  • Revenue
  • COEP N/A
  • ORIS $16,745,999.00
  • Revenue This Year
  • COEP N/A
  • ORIS N/A
  • Revenue Next Year
  • COEP N/A
  • ORIS N/A
  • P/E Ratio
  • COEP N/A
  • ORIS $2.65
  • Revenue Growth
  • COEP N/A
  • ORIS N/A
  • 52 Week Low
  • COEP $2.31
  • ORIS $1.12
  • 52 Week High
  • COEP $13.70
  • ORIS $21.24
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.40
  • ORIS N/A
  • Support Level
  • COEP $8.65
  • ORIS N/A
  • Resistance Level
  • COEP $13.70
  • ORIS N/A
  • Average True Range (ATR)
  • COEP 2.11
  • ORIS 0.00
  • MACD
  • COEP -0.24
  • ORIS 0.00
  • Stochastic Oscillator
  • COEP 61.22
  • ORIS 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.

Share on Social Networks: